Health Conditions

Alpha-2-hs-glycoprotein (analyte X3581.53) Levels

1 variant Other

Alpha-2-hs-glycoprotein Level in Chronic Kidney Disease with Hypertension and No Diabetes (10966_1)

1 variant Cardiovascular

Alpha-2-hs-glycoprotein Level in Chronic Kidney Disease with Hypertension and No Diabetes (3581_53)

1 variant Cardiovascular

Alpha-2-macroglobulin Receptor-associated Protein Level in Chronic Kidney Disease with Hypertension and No Diabetes (3640_14)

1 variant Cardiovascular

Alpha-2-macroglobulin-like Protein 1 Level in Chronic Kidney Disease with Hypertension and No Diabetes (15482_12)

1 variant Cardiovascular

Alpha-2,8-sialyltransferase 8b Levels

1 variant Other

Alpha-2,8-sialyltransferase 8f Levels

1 variant Other

Alpha-actinin-1 Levels

1 variant Other

Alpha-actinin-2 Levels

1 variant Other

Alpha-actinin-4 Levels

1 variant Other

Alpha-aminoadipic Semialdehyde Dehydrogenase Level in Chronic Kidney Disease with Hypertension and No Diabetes (21498_3)

1 variant Cardiovascular

Alpha-aminoadipic Semialdehyde Dehydrogenase Levels

1 variant Other

Alpha-amylase 2b (analyte X10439.57) Levels

1 variant Other

Alpha-amylase 2b (analyte X15556.49) Levels

1 variant Other

Alpha-cehc Sulfate Levels in Elite Athletes

1 variant Other

Alpha-cmbhc Glucuronide Levels

1 variant Other

Alpha-crystallin A Chain Levels

1 variant Other

Alpha-hemoglobin-stabilizing Protein Protein Levels (somascan Id:22155-44)

1 variant Hematologic

Alpha-hydroxyisocaproate Levels

1 variant Other

Alpha-hydroxyisocaproate Levels in Elite Athletes

1 variant Other

Alpha-internexin Levels

1 variant Other

Alpha-ketoglutaramate Levels

1 variant Other

Alpha-ketoglutarate-dependent Dioxygenase Alkb Homolog 3 Protein Levels (somascan Id:4920-10)

1 variant Other

Alpha-l-fucoside Fucohydrolase Level in Chronic Kidney Disease with Hypertension and No Diabetes (21384_2)

1 variant Cardiovascular

Alpha-linoleic Acid Levels and Trail Making Test A (interaction)

1 variant Other

Alpha-linoleic Acid Levels and Trail Making Test D (interaction)

1 variant Other

Alpha-n-acetylgalactosaminide Alpha-2,6-sialyltransferase 1 Levels

1 variant Other

Alpha-n-acetylgalactosaminide Alpha-2,6-sialyltransferase 2 Levels (st6galnac2.7823.22.3)

1 variant Other

Alpha-n-acetylgalactosaminide Alpha-2,6-sialyltransferase 3 Levels (st6galnac3.10626.116.3)

1 variant Other

Alpha-n-acetylgalactosaminide Alpha-2,6-sialyltransferase 6 Levels

1 variant Other

Alpha-n-acetylneuraminide Alpha-2,8-sialyltransferase (analyte X21508.7) Levels

1 variant Other

Alpha-n-acetylneuraminide Alpha-2,8-sialyltransferase Level in Chronic Kidney Disease with Hypertension and No Diabetes (21508_7)

1 variant Cardiovascular

Alpha-soluble Nsf Attachment Protein Levels

1 variant Other

Alpha-synuclein Levels (snca.8458.111.3)

1 variant Other

Alpha-taxilin Levels

1 variant Other

Alpha-taxilin Levels (txlna.9065.28.3)

1 variant Other

Alpha/beta Hydrolase Domain-containing Protein 14a Levels (abhd14a.5715.4.3)

1 variant Other

Alt X All Environments (sex, Age, Ever-drinking, Ever-smoking, Current-smoking, Japanese Cuisine, European Cuisine, Dairy Products, and Physical Activity) Interaction

1 variant Other

Alt X Commonly-tested Environments (sex, Age, Ever-drinking, Ever-smoking, and Current-smoking) Interaction

1 variant Other

Alt X Ever-drinking Interaction

1 variant Other

Alt X Ever-smoking Interaction

1 variant Other

Altered Mental Status (phecode 292.4)

1 variant Other

Alteromonadaceae Abundance in Stool

1 variant Other

Althete's Foot (phecode 110.12)

1 variant Other

Alzheimer's Disease (clinical and Registry Cases) (e-xci Inactivation)

1 variant Neurological

Alzheimer's Disease (clinical Cases) (r-xci Inactivation)

1 variant Neurological

Alzheimer's Disease Assessment Scale (12 Month Visit)(adjusted For Apoe E4 Dosage)

1 variant Neurological

Alzheimer's Disease Assessment Scale (24 Month Visit)(adjusted For Apoe E4 Dosage)

1 variant Neurological

Alzheimer's Disease Assessment Scale (6 Month Visit)(adjusted For Apoe E4 Dosage)

1 variant Neurological

Alzheimer's Disease Assessment Scale (baseline)(adjusted For Apoe E4 Dosage)

1 variant Neurological

Alzheimer's Disease in Apoe E4 Homozygosity

1 variant Neurological

Alzheimer's Disease or Body Fat Percentage (pleiotropy)

1 variant Neurological

Alzheimer's Disease or Ldl Levels (pleiotropy)

1 variant Neurological

Alzheimer's Disease or Small Vessel Stroke

1 variant Cardiovascular

Alzheimer's Disease or Systolic Blood Pressure (pleiotropy)

1 variant Cardiovascular

Alzheimer's Disease or Waist-hip Ratio (pleiotropy)

1 variant Neurological

Alzheimer’s Disease (clinical Subgroup Ad+)

1 variant Neurological

Alzheimer’s Disease (clinical Subgroup Ad++)

1 variant Neurological

Alzheimer’s Disease (clinical Subgroup Ad+++)

1 variant Neurological

Alzheimer’s Disease And/or Vascular Dementia (clinical Subgroup Vad+)

1 variant Neurological